Scholarlink

Introduction <p>An understanding of the differences among the invasive lobular breast carcinoma (ILC) variants is crucial for risk stratification, and tailored treatment planning. This article compares variants of ILC according to their clinical outcomes and histopathological features. </p> Patients and methods <p>Patients diagnosed with ILC between January 2010 and August 2021 were retrospectively evaluated. Patients were divided into three groups; 1: classic ILC (cILC); 2: pleomorphic lobular carcinoma (PLC); 3: mixed ILC. Mixed ILC was divided into three subgroups: 3a, cILC + PLC; 3b, cILC + mixed; 3c, PLC + mixed.</p> Results <p>A total of 254 patients were included in the study. Median overall survival (OS) was 48&#xa0;months, and median disease-free survival (DFS) was 46&#xa0;months. Locoregional recurrence (LRR) occurred in 15 (5.9%) of the patients, and distant metastasis (DM) developed in 23 (9.1%). Death occurred in 16 (6.3%) patients. There was no significant difference in LRR rate among groups. When considering five groups (Groups 1, 2, 3a, 3b, and 3c), the median OS was 62.5, 52.0, 50.8, 56.7, and 41.5&#xa0;months, respectively, while the median DFS was 60.3, 46.6, 46.7, 54.5, and 39.6&#xa0;months, respectively. Notably, the PLC + mixed group without a classic variant (Group 3c) exhibited even worse outcomes than pure PLC.</p> Conclusions <p>In this study, pure cILC exhibited the best prognostic features among the ILC variants. Furthermore, we observed a higher mastectomy rate in patients with pleomorphic variants. Surgical management of ILC remains controversial. Moreover, comprehensive randomized controlled trials are essential to establish standardized treatment protocols for ILC patients.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Invasive lobular breast carcinoma variants; clinicopathological features and patient outcomes

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年5月21日

查看全文
  • Aysegul Aktas,
  • Meryem Gunay Gurleyik,
  • Dogukan Akkus,
  • Zekeriya Ucur,
  • Fugen Aker

摘要

Introduction

An understanding of the differences among the invasive lobular breast carcinoma (ILC) variants is crucial for risk stratification, and tailored treatment planning. This article compares variants of ILC according to their clinical outcomes and histopathological features.

Patients and methods

Patients diagnosed with ILC between January 2010 and August 2021 were retrospectively evaluated. Patients were divided into three groups; 1: classic ILC (cILC); 2: pleomorphic lobular carcinoma (PLC); 3: mixed ILC. Mixed ILC was divided into three subgroups: 3a, cILC + PLC; 3b, cILC + mixed; 3c, PLC + mixed.

Results

A total of 254 patients were included in the study. Median overall survival (OS) was 48 months, and median disease-free survival (DFS) was 46 months. Locoregional recurrence (LRR) occurred in 15 (5.9%) of the patients, and distant metastasis (DM) developed in 23 (9.1%). Death occurred in 16 (6.3%) patients. There was no significant difference in LRR rate among groups. When considering five groups (Groups 1, 2, 3a, 3b, and 3c), the median OS was 62.5, 52.0, 50.8, 56.7, and 41.5 months, respectively, while the median DFS was 60.3, 46.6, 46.7, 54.5, and 39.6 months, respectively. Notably, the PLC + mixed group without a classic variant (Group 3c) exhibited even worse outcomes than pure PLC.

Conclusions

In this study, pure cILC exhibited the best prognostic features among the ILC variants. Furthermore, we observed a higher mastectomy rate in patients with pleomorphic variants. Surgical management of ILC remains controversial. Moreover, comprehensive randomized controlled trials are essential to establish standardized treatment protocols for ILC patients.